Inmagene Site 1 — New York, New York

Inmagene Site 1 is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Inmagene Site 1 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema.

Sponsors: Inmagene LLC.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Inmagene Site 1?

Inmagene Site 1 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Inmagene Site 1 conducted?

Inmagene Site 1 has 1 clinical trials on record, with 1 currently active. Their work covers Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema.

Is Inmagene Site 1 accredited by Crixeo Health?

Inmagene Site 1 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Inmagene Site 1?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.